Topical Treatment for Inflammatory Bowel Disease Pouchitis Starts Pivotal Phase 3 Trial, Now Enrolling Patients


Read about a Phase 3 trial to assess alicaforsen as a topical daily treatment for inflammatory bowel disease pouchitis that is now recruiting participants.



Source by ibdnewstoday